The prognostic importance of creatinine clearance after acute myocardial infarction

European Heart Journal

Volumn 23, Issue 12, 2002, Pages 948-952

  Sorensen C R ^a   Brendorp, B ^a   Rask Madsen, C ^a   Kober L ^b   Kjoller E ^c   Torp Pedersen, Christian ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

^c AMAGER HOSPITAL   (Denmark)

Author keywords

Acute myocardial infarction; Impairment; Prognosis; Renal dysfunction

Indexed keywords

CREATININE; FIBRINOLYTIC AGENT; PLACEBO; TRANDOLAPRIL;

ACUTE HEART INFARCTION; ADULT; AGE; AGED; ANGINA PECTORIS; ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COVARIANCE; CREATININE CLEARANCE; DOUBLE BLIND PROCEDURE; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; HYPERTENSION; KIDNEY DYSFUNCTION; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONBIOLOGICAL MODEL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SEX DIFFERENCE;

ADULT; AGED; COHORT STUDIES; CREATININE; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PATIENT ADMISSION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 0036623942     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2001.2989     Document Type: Article

References (22)

1. Brophy JM, Deslauriers G, Rouleau JL. Long-term prognosis of patients presenting to the emergency room with decompensated congestive heart failure. Can J Cardiol 1994; 10: 543-7.
2. Parving HH. Diabetic hypertensive patients. Is this a group in need of particular care and attention? Diabetes Care 1999; 22 (Suppl 2): B76-9.
3. Mailloux LU, Haley WE. Hypertension in the ESRD patient: Pathophysiology, therapy, outcomes, and future directions. Am J Kidney Dis 1998; 32: 705-19.
4. Mimran A, Ribstein J. Antihypertensive therapy in renal disease and transplantation. J Hypertens Suppl 1992; 10: S79-85.
5. Textor SC. Atherosclerotic renovascular disease as a cause of end-stage renal disease: Cost considerations. Blood Purif 1996; 14: 305-14.
6. Wannamethee SG, Shaper AG, Perry IJ. Serum creatinine concentration and risk of cardiovascular disease: A possible marker for increased risk of stroke. Stroke 1997; 28: 557-63.
7. Alcorn HG, Wolfson SK, Jr, Sutton-Tyrrell K, Kuller LH, O'Leary D. Risk factors for abdominal aortic aneurysms in older adults enrolled in The Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 1996; 16: 963-70.
8. Pahor M, Shorr RI, Somes GW et al. Diuretic-based treatment and cardiovascular events in patients with mild renal dysfunction enrolled in the systolic hypertension in the elderly program. Arch Intern Med 1998; 158: 1340-5.
9. McCullough PA, Soman SS, Shah SS et al. Risks associated with renal dysfunction in patients in the coronary care unit. J Am Coll Cardiol 2000; 36: 679-84.
10. Torp-Pedersen C, Kober L, Ottesen M, TRACE study group. Influence of gender on short and long term survival after acute myocardial infarction. ESC Meeting, Amsterdam 1995.
11. Kober L, Torp-Pedersen C, Carlsen JE et al. A clinical trial of the angiotensin converting enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1995; 333: 1670-6.
12. Group TTS. The TRAndolapril Cardiac Evaluation (TRACE) study: Rationale, design and baseline characteristics of the screened population. Am J Cardiol 1994; 73: 44c-50c.
13. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
14. Heger JJ, Weymann AE, Wann S, Rogers EW, Dillon JC, Feigenbaum H. Cross-sectional echocardiographic analysis of the extent of left ventricular asynergy in acute myocardial infarction. Circulation 1980; 61: 1113-18.
15. Berning J, Steensgaard-Hansen F. Early estimation of risk by echocardiographic determination of wall motion index in an unselected population with acute myocardial infarction. Am J Cardiol 1990; 65: 567-76.
16. Berning J, Rokkedal Nielsen J, Launbjerg J, Fogh J, Mickley H, Andersen PE. Rapid estimation of left ventricular ejection fraction in acute myocardial infarction by echocardiographic wall motion analysis. Cardiology 1992; 80: 257-66.
17. Kober L, Torp-Pedersen C, Carlsen J, Videbaek R, Egeblad H, TRACE study group. An echocardiographic method for selecting high risk patients shortly after acute myocardial infarction, for inclusion in multi-centre studies (as used in the TRACE study). Eur Heart J 1994; 15: 1616-20.
18. Kober L, Torp-Pedersen C, Ottesen M et al. Influence of gender on short- and long-term mortality after acute myocardial infarction. Am J Cardiol 1996; 77: 1052-6.
19. McLigeyo SO. Smoking - An emerging risk factor for renal diseases. East Afr Med J 1998; 75: 171-4.
20. Jorgensen, Kober L, Ottesen MM, Torp-Pedersen C, Videbaek J, Kjoller E. The prognostic importance of smoking status at the time of acute myocardial infarction in 6676 patients. TRACE Study Group. J Cardiovasc Risk 1999; 6: 23-7.
21. Maynard C, Althouse R, Cerqueira M, Olsufka M, Kennedy JW. Underutilization of thrombolytic therapy in eligible women with acute myocardial infarction. Am J Cardiol 1991; 68: 529-30.
22. London GM. Vascular disease and atherosclerosis in uremia. Blood Purif 2001; 19: 139-42.